Joshua Ginzel

6PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 19, 2025
Nonlinear progression during the occult transition establishes cancer lethality.

Joshua D Ginzel, Henry Chapman, Joelle E Sills

|May 07, 2024
Nonlinear progression during the occult transition establishes cancer lethality.

Joshua D Ginzel, Henry Chapman, Joelle E Sills

|Oct 22, 2021
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study.

Takuya Osada, Erika J Crosby, Kensuke Kaneko

|Jun 16, 2021
HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase.

Joshua D Ginzel, Chaitanya R Acharya, Veronica Lubkov

|May 10, 2020
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors.

Kensuke Kaneko, Takuya Osada, Michael A Morse

Pageof 1